Aims: Elevated serum lipid concentrations in childhood are thought to be risk factors for the development of cardiovascular disease later in life. The present study aims to provide age-and gender-related reference intervals for total cholesterol (TC), high-density lipoprotein (HDL) cholesterol, and non-HDL cholesterol in healthy school children. We also investigated the prevalence of dyslipidaemia using the published criteria for these biomarkers. Methods: Venous blood and anthropometric data were collected from 1340 children in the HOPP study, aged between 6 and 12 years. Age-and gender-related reference intervals (2.5th and 97.5th percentiles) were established according to the IFCC recommendations, using the software RefVal 4.10. Results: Gender differences were observed for total cholesterol and non-HDL cholesterol, but not for HDL cholesterol. Age differences were observed for total cholesterol. The reference intervals were in the range of 3.1-5.9 mmol/L for total cholesterol, 1.0-2.4 mmol/L for HDL cholesterol and 1.4-4.2 mmol/L for non-HDL cholesterol. Dyslipidaemia prevalence was as follows: increased TC 9.6%, decreased HDL 1.6%, and increased non-HDL 5.6%. Conclusions: Age-and gender-related reference intervals in a Norwegian population are similar to those reported in other countries. The prevalence of dyslipidaemia among Norwegian children is significant, emphasising the importance of appropriate reference intervals in clinical practice.
Introduction
With ischaemic heart disease being the most common cause of death worldwide [1] , identifying and addressing risk factors as early as possible is of monumental importance. Hyperlipidaemia as a risk factor for the development of cardiovascular disease (CVD) is well established in adults [2, 3] . CVD is most often manifested after the fourth decade of life [4] . However, it has become evident that changes in blood lipid risk factors begin in early childhood [5] , especially in genetically disposed children [4] . In addition, signs of early stages of atherosclerosis are detectable in childhood [6, 7] . Hyperlipidaemia in children is associated with atherosclerosis in adulthood [8, 9] . It is therefore important to have valid reference intervals available to identify children at risk as early as possible.
Interpretation of medical laboratory results is based on comparison, and a single result is not medically useful without appropriate reference data available. Reference intervals, along with previous results from the same subject, are an essential tool in this task. Reference values should be derived from healthy persons in a relevant population. Establishing reference intervals is cumbersome and poses additional challenges in children, as samples from healthy children are not easily obtainable. Therefore, laboratories often chose to use reference intervals from the literature. However, the commutability of such data is often insufficiently documented [10] . Differences in both method and population may introduce bias that renders the intervals invalid to the population in question. Hence, there is a constant need to prepare and validate reference intervals.
The present study provides reference intervals in non-fasting healthy children for total cholesterol, high-density lipoprotein (HDL) cholesterol, and non-HDL cholesterol. In addition, we examined the prevalence of dyslipidaemia in the present cohort of 1340 Norwegian school children aged 6-12 years.
Methods
The study population was recruited from the Health Oriented Pedagogical Project (HOPP), a controlled longitudinal school-based physical activity intervention programme. The project is registered as a clinical trial (ClinicalTrials.gov Identifier: NCT02495714) and is described in detail elsewhere [11] . The main objective is to evaluate the effects of a school-based physical activity intervention programme on cardiometabolic risk factors. Children from nine primary schools in south-east Norway were invited, giving a baseline participation rate of 2297 (82%) children. Blood samples are to be taken annually. However, not all children comply with this procedure. The children were given an opportunity to opt out of the blood sample test, while participating in the other test procedures. Children who had had infections during the previous week were asked not to donate a blood sample; hence, the present study population consists of 58.4% of the children (n = 1340, n = 650 girls) who completed blood sample procedures at baseline. Age was defined as age at the day of venepuncture. The ethnicity of the children was not registered; however, the majority of the children were of Caucasian origin.
Blood samples were collected in the non-fasting state between 8:00 a.m. and 1:30 p.m. The children were summoned from the classroom in groups of four, without strenuous exercise prior to sample collection. Blood was drawn from the antecubical vein in 4 mL serum tubes with serum separator and clot activator (Vacuette®, Greiner Bio-One, Austria) by a trained phlebotomist. After 30 min of coagulation, the gel tube was centrifuged at 2000g for 10 min. At the end of each collection session, samples were transported to the central laboratory at Vestfold Hospital Trust and immediately analysed according to standard procedures. The laboratory is accredited is in accordance with NS-EN ISO 15189. Indices for haemolysis, icterus, and lipaemia were measured on all samples and handled according to laboratory rules. Total cholesterol and HDL cholesterol were analysed on Vitros 5.1 (Ortho-Clinical Diagnostics, USA) with reagents from the supplier. Non-HDL cholesterol was calculated as total cholesterol minus HDL cholesterol. Analytical imprecision (CV%) estimated from internal quality control for total cholesterol and HDL cholesterol was 1.8% and 2.7%, respectively. The Serum X from the NORIP project provided a reference material with assigned values traceable to reference methods [12] . Serum X has a certified value for cholesterol traceable to reference methods, and an indicative value of HDL cholesterol. In addition, commutability was ascertained by participation in inter-laboratory external proficiency testing schemes from EQUALIS [13] . Dyslipidaemia was defined as total cholesterol ≥ 5.2 mmol/L, HDL cholesterol < 1.0 mmol/L or non-HDL cholesterol ≥ 3.8 mmol/L or a combination thereof [14] .
Statistics
Age and gender partitioning of the reference values were initially proposed based on previously published reference values [15] [16] [17] , together with a graphic visualisation of our data. Subsequently, we made a formal evaluation according to the criteria introduced by Lahti et al. [18] . In brief, if <0.9% or >4% of each sub-distribution is outside the reference limit (2.5th and 97.5th percentiles) of the common distribution, partitioning is recommended. The 2.5th and 97.5th percentiles with corresponding 95% confidence intervals (CIs) for each group were calculated using the bootstrap technique according to the IFCC recommendations, using the software RefVal 4.10 [19] . No outliers were detected with the incorporated Dixon algorithm. Data handling was performed using the statistical software R (version 3.4.3) [20] . Smoothed percentile curves were generated using the Generalized Additive Models for Location Scale and Shape (GAMLSS) package with the Box-Cox power exponential distribution family [21] .
Ethics and consent to participate
The Regional Committees for Medical and Health Research Ethics approved the study protocol (2014/2064/REK sør-øst). The study is registered in as a clinical trial (ClinicalTrials.gov Identifier: NCT02495714). All children included in the study provided written parental consent. At the same time, participants were able to withdraw from the study at any stage of data collection without explanation.
Results
Figure 1 displays a histogram for age and sex distribution of the study population while descriptions are presented in Table I . Reference intervals for serum total cholesterol, HDL cholesterol, and non-HDL cholesterol (2.5th percentile and 97.5th percentile) are shown in Table II , and smoothed percentile curves are shown in Figures 2-4 .
Gender differences were observed for total cholesterol and non-HDL cholesterol, but not for HDL cholesterol. Age differences were observed for total cholesterol. The reference intervals were in the range of 3.1-5.9 mmol/L for total cholesterol, 1.0-2.4 mmol/L for HDL cholesterol, and 1.4-4.2 mmol/L for non-HDL cholesterol. More specifically, the ref-
mmol/L for girls and 1.4-4.0 mmol/L for boys. The percentile curves display the 2.5th, 50th, and 97.5th percentiles for total cholesterol, HDL cholesterol, and non-HDL cholesterol, stratified by gender.
For total cholesterol, girls tend to show higher values around 10 years, possibly due to the onset of menarche. A similar pattern is visible for non-HDL cholesterol, while HDL cholesterol remains stable across age groups. The prevalence of dyslipidaemia in the HOPP study was compared to the prevalence in a Danish population [14] , a German population [15] , and the United States of America [6] ; results are presented in Table III . The total cholesterol was ≥ 5.2 mmol/L for 9.6% (n = 129) of the children. For HDL cholesterol, 1.6% (n = 22) of the children had <1.0 mmol/L, while 5.6% (n = 75) had a non-HDL cholesterol level ≥ 3.8 mmol/L.
Discussion
This study provides reference intervals for non-fasting plasma concentrations of total cholesterol, HDL cholesterol and non-HDL cholesterol from a Norwegian paediatric population. In addition, we present the prevalence of dyslipidaemia for these biomarkers.
Establishing reference intervals is cumbersome and poses additional challenges in children, as samples from healthy children are not easily obtainable. Therefore, it is common to derive reference intervals from small samples or from laboratory databases using various techniques to extract results from presumably healthy children. However, both these approaches are considered suboptimal [22] . Laboratories often chose to use reference intervals from the literature. However, the commutability of such data is often insufficiently documented [10] . Differences in both method and population may introduce bias that renders the intervals invalid for the population in question. Hence, there is a constant need to prepare and validate reference intervals.
A major strength of the present study is the recruitment of a large study population outside the hospital persistent dyslipidaemia, atherosclerosis, and future cardiovascular events than TC, LDL cholesterol, or HDL cholesterol levels alone [4] . Non-HDL cholesterol can be accurately calculated in a non-fasting state and is therefore practical to measure in clinical practice. Lipid status is dependent on many factors. Ethnicity, gender, food intake, fasting/non-fasting, and stature all influence the results. In addition, population characteristics may change -as in the obesity epidemic, for example -rendering reference intervals invalid as time goes by. Therefore, there is a continuous need to establish and verify reference intervals in the clinical laboratory. There are three recent studies from Nordic populations presenting similar data [15, 16, 23] . Although analyses were performed on different platforms (Abbott® Architect ci8200 and Roche® Modular P system), both Aldrimer et al. and Hilsted et al. collected non-fasting samples and used the NFKK reference serum X to secure commutability [15, 16] . Nevertheless, results from Sweden show slightly higher total cholesterol and lower HDL cholesterol as compared to Denmark and the present Norwegian study population. Nielsen et al. reported plasma lipid concentrations in a population-based cohort recruited from schools in 11 municipalities across Denmark [23] . The authors report age-stratified reference ranges from 6 to 19 years. When extracting the age groups corresponding to the present study, this yields somewhat lower values, possibly explained by the fasting state of the participants in that study. Finally, Dathan-Stumpf et al. collected fasting samples from healthy children in Germany, Table III . Prevalence of dyslipidaemia in the HOPP study (n = 1340), as a representative sample of Norway, compared to the occurrence of dyslipidaemia in Denmark, Germany, and the US. 14, 23, 24 HOPP/Norway Denmark Germany USA Total cholesterol (≥ 5.2 mmol/L) n = 129 9.6% 3.3%* 7.8%* 8% HDL cholesterol (< 1.0 mmol/L) n = 22 1.6% 1.6%** 8% 13-15% non-HDL cholesterol (≥ 3.8 mmol/L) n = 75 5.6% --8-12% *>5.2 mmol/L, ** <0.9 mmol/L. presenting age-and gender-related reference intervals (3rd and 97th percentiles) [24] . The reported reference intervals were in the range of 2.97-5.79 mmol/L for total cholesterol and 0.92-2.55 for HDL cholesterol, more in line with our results. The prevalence of dyslipidaemia in the present study show some interesting features compared to other published data (Table III) . As compared to Denmark [23] , Germany [24] , and the United States [14] , the prevalence of hypercholesterolemia in Norway is in line with observations in Germany and the United States, but higher than reported from Denmark. The opposite is observed for HDL cholesterol. While the hypercholesterolemia reported from the Danish and German population is based on a slightly different definition of dyslipidaemia, > 5.2 mmol/L (not ≥ 5.2 mmol/L), this does not account for the much lower prevalence of hypercholesterolemia in the Danish population. The prevalence in the Norwegian population (5.6%) is lower than reported from the United States (8-12%); no data for non-HDL cholesterol is reported from Denmark or Germany. The observed differences in prevalence of dyslipidaemia could suggest differences in population characteristics. They also show that the different criteria for dyslipidaemia are targeting different individuals. However, the current definition of dyslipidaemia includes a single criterion, or any combination of the listed criteria [14] . As dyslipidaemia in adolescents is linked with risk of CVD in adults, it would be of interest to determine whether the trends in dyslipidaemia discussed here reflect differences in cardiovascular morbidity. Ischemic heart disease mortality and mortality related to problems of the circulatory system are much higher in the United States and Germany than in Norway and Denmark [25] . This matches the HDL cholesterol trend but not total cholesterol. However, dyslipidaemia is only one of several risk factors for CVD, and other risk factors are likely to affect the mortality rates in combination with dyslipidaemia.
Limitations
Our study has some limitations. Because blood samples were collected in a non-fasting state, triglycerides were not measured, although resent data show the validity of non-fasting values also for triglycerides [26] . Ethnicity was not recorded and thus could introduce additional variance not adjusted for. The present study population was recruited from two neighbouring Norwegian counties, and may not be representative of the Norwegian paediatric population in general. No information about genetic predisposition was collected from this population, and thus the prevalence of familiar hypercholesterolemia (FH) is not known. This is not likely to influence the estimated reference intervals because of the large number of study participants. Finally, the onset of menarche and puberty was not recorded. However, a similar study in a Nordic population found that the effects of puberty on lipid concentrations did not differ from the effects of age [23] .
Conclusion
This study provides reference intervals for total cholesterol, HDL cholesterol, and non-HDL cholesterol for non-hospitalised children aged 6-12 years. The results are commutable across analytical platforms due to the use of NFKK Reference Serum X. The prevalence of dyslipidaemia among Norwegian children is significant, emphasising the importance of appropriate reference intervals in clinical practice.
